|
Volumn 19, Issue 4, 2013, Pages 840-846
|
A shift from oral to intravenous iron supplementation therapy is observed over time in a large swiss cohort of patients with inflammatory bowel disease.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IRON;
ARTICLE;
COHORT ANALYSIS;
COMPARATIVE STUDY;
CROHN DISEASE;
DIET SUPPLEMENTATION;
FEMALE;
FOLLOW UP;
HUMAN;
INTRAVENOUS ADMINISTRATION;
MALE;
MIDDLE AGED;
ORAL DRUG ADMINISTRATION;
SOCIOECONOMICS;
SWITZERLAND;
TREATMENT OUTCOME;
ULCERATIVE COLITIS;
ADMINISTRATION, INTRAVENOUS;
ADMINISTRATION, ORAL;
COHORT STUDIES;
COLITIS, ULCERATIVE;
CROHN DISEASE;
DIETARY SUPPLEMENTS;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IRON;
MALE;
MIDDLE AGED;
SOCIOECONOMIC FACTORS;
SWITZERLAND;
TREATMENT OUTCOME;
|
EID: 84884608266
PISSN: None
EISSN: 15364844
Source Type: None
DOI: 10.1097/MIB.0b013e31827febbb Document Type: Article |
Times cited : (11)
|
References (0)
|